1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
Book a demo
-
  1. My Preqin
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
  1. My Preqin
Book a demo

MedImmune Ventures

Have updates for this profile?  Please contribute data

Overview Known Decision Makers Private Capital Funds Managed
= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Type

Private Equity Firm

Location

Gaithersburg MD US

Alternative Asset Classes

PE PD

Established

2002

Firm Ownership

Captive Arm – Corporate

Investment Team Staff

Total Staff

-
MedImmune Ventures is a wholly-owned venture capital firm within the AstraZeneca/MedImmune group of companies. MedImmune Ventures invests in early- to late-stage, public or private biotechnology companies focused on discovering and developing human therapeutics across North America, US. The firm primarily seeks to invest in areas of strategic interest to Astra Zeneca and MedImmune, including infectious diseases, cancer, inflammatory diseases, cardiovascular and metabolic disorders, pain and central nervous system disorders, and gastrointestinal disease. MedImmune invests anywhere in the world where it has strong local relationships.
Asset Class No. of Funds Currently Managed Funds Raised in Last 10 Years Est. Dry Powder Strategies
Private Equity 1 Early Stage, Early Stage: Seed, Early Stage: Start-up, Expansion / Late Stage, Growth, Venture (General)
Real Estate - -
Private Debt - Mezzanine
Infrastructure - -
Natural Resources - -
Asset Class No. of Funds Currently Managed AuM Date of AuM Strategies
Hedge Funds 0 -

Want to see more?

Request a demo for full access to this profile.

5 Known Decision Makers

Contact Name Position Location Email Telephone Asset Class
President of China & Executive Vice President of International Pudong, China PE VC
President, MedImmune & Executive Vice President, AstraZeneca Gaithersburg, US PE PD
Executive Vice President, Vaccines & Immune Therapies Cambridge, UK PE
Executive Director & Chief Executive Officer Cambridge, UK PE
Chief Executive Officer & Chief Strategy Officer Cambridge, UK PE VC PD

Showing 5 of 5 known decision makers at MedImmune Ventures

Preqin screens the most influential contacts in alternatives, so you only reach the key decision makers

Request a Demo to see more

1 Private Capital Funds Managed

Fund Name Vintage Strategy Status Fund Structure Closed Size (MN) Target Size (MN) Primary Region Focus
Venture (General) Evergreen Commingled North America

Showing 1 of 1 private capital fund managed by MedImmune Ventures

Request a Demo to see more

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.
Sign in Request demo